Navigation Links
Excluding the lateral view in chest radiograph screenings decreases radiation exposure by 67 percent

For the patient with a positive PPD test, which usually indicates prior exposure to tuberculosis, the guidelines recommend a chest x-ray that typically includes a frontal and lateral view. The lateral view, which accounts for 2/3 of the total radiation dose during screening, is not necessary, according to a study performed at the Beth Israel Deaconess Medical Center in Boston, MA.

Chest radiographs, including a lateral view, were taken in 857 patients with positive PPD (tuberculosis) screenings. Abnormalities were detected in 91 of them. "In no case did the lateral view show any abnormality that was not shown on the frontal view, nor did it improve visualization," said Ronald Eisenberg, MD, lead author of the study. "Eliminating the lateral view would reduce a patient's overall radiation exposure by about 67 percent," said Dr. Eisenberg.

"The current guidelines recommend that everyone who has a positive tuberculosis test should have a chest radiograph. We evaluated individuals for pre-employment purposes who were asymptomatic and concluded that there is no need to take a lateral view in this situation," said Dr. Eisenberg. "However, each individual institution will have to decide for itself whether it is appropriate or not," he said.

"I believe that all radiologists should always try to limit the radiation dose to our patients as much as possible. Eliminating the lateral view of the chest in this specific situation will decrease radiation exposure and will streamline the work flow for technologists," said Dr. Eisenberg.


Contact: Heather Curry
American Roentgen Ray Society

Page: 1

Related medicine news :

1. Nuclear medicine approach can be first choice for excluding pulmonary embolism in young women
2. Sanofi-aventis Q3 2008 Adjusted EPS Excluding Selected Items(1):
3. Medco Reports Record Third-Quarter 2008 GAAP Diluted EPS of $0.58; Diluted EPS Excluding Amortization of Intangible Assets of $0.63
4. BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
5. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
6. SBi Launches rHead(TM) Lateral Radial Head Implant and rHead(TM) Plating Systems to Expand its Elbow Management System
7. Early treatment of children with bilateral amblyopia essential, according to multisite study
8. Bilateral cochlear implants: A case when 2 are definitely superior to 1
9. Pioneer(R) Surgical Technology Announces the Market Release of its Cross-Fuse(TM) Lateral Vertebral Body Replacement (VBR) System
10. Researchers identify risk factors for contralateral breast cancer
11. News briefs from the journal Chest, August 2007
Post Your Comments:
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Research and Markets has announced the ... report to their offering. ... favourable commercial environment for MedImmune to enter. The US ageing ... serve to drive considerable growth for effective anti-influenza medications. The ... sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... environments  Oticon , industry leaders in ... the launch of Oticon Opn ™, the world,s ... world of possibilities for IoT devices.      ... Opn, Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology: